Pharmacogenomics of antihypertensive drug response: new evidence of miRNA controlling blood pressure.

about

Pharmacogenomics of antihypertensive drug response: new evidence of miRNA controlling blood pressure.

Item

http://www.wikidata.org/entity/Q44145967

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@en

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@nl

type

Item

label

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@en

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@nl

prefLabel

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@en

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@nl

P1476

Pharmacogenomics of antihypert ...... NA controlling blood pressure.

@en

P2093

Alvaro Cerda

http://www.w3.org/2001/XMLSchema#string

Mario H Hirata

http://www.w3.org/2001/XMLSchema#string

Rosario D C Hirata

http://www.w3.org/2001/XMLSchema#string

P2860

Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study

SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas

Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein in human plasma.

Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes

Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.

A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals

Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.

Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans.

P304

1819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.13.179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258632013

http://www.w3.org/2001/XMLSchema#string

P698

24386647

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics